source
- Eli Lilly to acquire AtaiBeckley in up to $3.8 billion deal, entering psychedelics marketEli Lilly announced it will buy AtaiBeckley, offering $6.75 per share for the company’s common stock. The transaction includes an upfront commitment of about $2.8 billion and a contingent value rig…
- UnitedHealth beats Q2 forecasts but warns rising insurance costs will strain employersUnitedHealth Group reported second-quarter results that exceeded analysts' expectations, lifting its shares modestly. Despite the upbeat earnings, executives highlighted that medical expenses for…